Ke Guo
Central South University
4 Papers
8 Citations
Ke Guo is an academic researcher from Central South University. The author has contributed to research in topics: Phosphorylation & microRNA. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
MiR-221-3p targets ARF4 and inhibits the proliferation and migration of epithelial ovarian cancer cells.
Qihui Wu,Xiaolei Ren,Yimin Zhang,Xiaodan Fu,Yimin Li,Yulong Peng,Qing Xiao,Tong Li,Chunli Ouyang,Yixi Hu,Yu Zhang,Wenjuan Zhou,Wenguang Yan,Ke Guo,Wei Li,Yongbin Hu,Xiaojing Yang,Guang Shu,Haofan Xue,Zhangming Wei,Yonghong Luo,Gang Yin +21 more
TL;DR: The research uncovered the tumor suppressive role of miR-221-3p in EOC and directly targeted ARF4, suggesting that miR -221- 3p might be a novel potential candidate for clinical prognosis and therapeutics of EOC.
58
MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
Xiaodan Fu,Yimin Li,Ayesha B. Alvero,Juanni Li,Qihui Wu,Qing Xiao,Yulong Peng,Yongbin Hu,Xiang Li,Wenguang Yan,Ke Guo,Wenjuan Zhou,Yong Wang,Junwen Liu,Yu Zhang,Gil Mor,Jifang Wen,Gang Yin +17 more
TL;DR: It is found that higher expression of miR-222-3p was associated with better overall survival in EOC patients, and its level was negatively correlated with tumor growth in vivo, and the characterization of a novel regulatory axis in ovarian cancer cells, miR+3p/GNAI2/AKT is described.
Effect of selective serotonin reuptake inhibitors on expression of 5-HT1AR and neurotransmitters in rats with vascular dementia.
TL;DR: Model animals demonstrated elongated escape latency, lower platform crossing times, and significant injuries to hippocampal CA1 neurons, suggesting that SSRIs may improve cognitive dysfunction of VD rats, possibly by stimulating expression of neurotransmitters and protecting neurons.
A Study on Expression and Tyrosine 705 phosphorylation of STAT3 in Focal Cerebral Ischemia-Reperfusion Rat Model and its Role in Neuronal Apoptosis
TL;DR: Regulating expression and tyrosine 705 phosphorylation of STAT3 may be a new and effective strategy for treating cerebral infarction.